Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1

Status

Completed 366Terminated 104Recruiting 92Unknown 58Active not recruiting 53Withdrawn 22Not yet recruiting 17No longer available 10Available 8Suspended 4Approved for marketing 3Enrolling by invitation 2Temporarily not available 1

Sponsor Class

OTHER 9NIH 5INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 21Other hematologic neoplasm 15Genitourinary 14Breast 14Other solid neoplasm 12Thoracic 11Lymphoid 10Dermatologic 10Gynecologic 8Tumor-Agnostic 7CNS 7Sarcoma 4Myeloid 4Plasma cell 3Head & Neck 2Endocrine 1

Conditions

Sarcoma 2Neoplasm Metastasis 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Osteosarcoma 1Melanoma 1Lymphoma 1Leukemia 1Gastrointestinal Stromal Tumors 1Endometrial Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Burkitt Lymphoma 1Breast Neoplasms 1

Interventions

pegamotecan 1RFB4(dsFv)-PE38 recombinant immunotoxin 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Suspended × INDUSTRY × Sarcoma × Clear all
NCT05958199 2025-06-27

A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

NextPoint Therapeutics, Inc.

Phase 1 Suspended
131 enrolled
BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Osteosarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT04714983 2024-04-09

DNX-2440 for Resectable Colorectal Liver Metastasis

DNAtrix, Inc.

Phase 1 Suspended
30 enrolled
BreastDermatologicGastrointestinalGenitourinarySarcoma

Breast Neoplasms, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Melanoma, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

NCT00079950 2012-09-06

Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma

Enzon Pharmaceuticals, Inc.

Phase 2 Suspended
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT00077493 2007-12-28

BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

MedImmune LLC

Phase 1 Suspended
95 enrolled
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡